Product Launch: Vaccinia Capping System mRNA Guanylyltransferase and mRNA Methyltransferase
mRNA Vaccinia Capping System: Proven. Scalable.
Tailored to the needs of biopharma companies developing mRNA-based therapies
A decade of capping enzyme experience, now available for you:
Roche’s vaccinia capping enzymes
Quality by design
Fit-for-purpose & GMP Grade to ensure compliance and minimize your overall risks
Scalable solution
Suitable for various scales of mRNA production from R&D to commercial manufacturing
Robust supply
Enhance business continuity and benefit from greater financial control
Proven expertise
A decade of manufacturing capping enzymes - before, during and beyond the COVID-19 pandemic
Ready to discover CustomBiotech's Vaccinia Capping System?
Request your test sample here
Webinar recoding: Evaluating mRNA capping systems: experimental strategies for mRNA manufacturing
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Source from a strong partner for robust supply
Roche CustomBiotech is ready to support your mRNA project
Discover more
Regulatory disclaimers, warranty limitations and legal notes are listed on the respective product pages.
